Fluzone Quadrivalent FDA Approval History
Last updated by Judith Stewart, BPharm on Oct 28, 2020.
FDA Approved: Yes (First approved June 7, 2013)
Brand name: Fluzone Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Suspension for Intramuscular Injection
Treatment for: Influenza Prophylaxis
Fluzone Quadrivalent is an inactivated influenza virus vaccine indicated for active immunization against influenza disease in people 6 months of age and older.
Development timeline for Fluzone Quadrivalent
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.